Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.
about
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness.Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase.The downregulation of putative anticancer target BORIS/CTCFL in an addicted myeloid cancer cell line modulates the expression of multiple protein coding and ncRNA genes.
P2860
Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Deregulated expression of HDAC ...... disease and lymphoma in mice.
@en
Deregulated expression of HDAC ...... disease and lymphoma in mice.
@nl
type
label
Deregulated expression of HDAC ...... disease and lymphoma in mice.
@en
Deregulated expression of HDAC ...... disease and lymphoma in mice.
@nl
prefLabel
Deregulated expression of HDAC ...... disease and lymphoma in mice.
@en
Deregulated expression of HDAC ...... disease and lymphoma in mice.
@nl
P2093
P2860
P50
P356
P1476
Deregulated expression of HDAC ...... e disease and lymphoma in mice
@en
P2093
Arthur Zelent
Chae H Kim
Jiyuan Zhang
Louise Howell
Sven Stengel
Veronica S Gil
P2860
P304
P356
10.1242/DMM.023366
P577
2016-10-28T00:00:00Z